Testosterone enanthate
 | |
| Clinical data | |
|---|---|
| Routes of administration | Intramuscular injection |
| Pharmacokinetic data | |
| Biological half-life | 4.5 days (intramuscular)[1] |
| Identifiers | |
| |
| Synonyms | NSC-17591 |
| CAS Number | 315-37-7 |
| PubChem (CID) | 9416 |
| ChemSpider | 9045 |
| UNII | 7Z6522T8N9 |
| KEGG | D00958 |
| ChEBI | CHEBI:9464 |
| ChEMBL | CHEMBL1200335 |
| Chemical and physical data | |
| Formula | C26H40O3 |
| Molar mass | 400.60 g·mol−1 |
| 3D model (Jmol) | Interactive image |
| |
| |
Testosterone enanthate (USAN, BAN) (brand names Delatestryl, Testostroval, Testro LA, Andro LA, Durathate, Everone, Testrin, Andropository), or testosterone heptanoate, is an androgen and anabolic steroid and a testosterone ester.[2][3][4] Along with testosterone cypionate and testosterone propionate, it is one of the most widely used testosterone esters.[5] Testosterone enanthate was first introduced in 1952.[6] Administered via intramuscular injection, it is the most widely used form of testosterone in androgen replacement therapy.[6]
Testosterone enanthate has an elimination half-life of 4.5 days and a mean residence time of 8.5 days when used as a depot intramuscular injection.[1] It requires frequent administration of approximately once per week, and large fluctuations in testosterone levels result with it, with levels initially being elevated and supraphysiological.[1]
References
- 1 2 3 Anita H. Payne; Matthew P. Hardy (28 October 2007). The Leydig Cell in Health and Disease. Springer Science & Business Media. pp. 423–. ISBN 978-1-59745-453-7.
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–642. ISBN 978-1-4757-2085-3.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ISBN 978-3-88763-075-1.
- ↑ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
- ↑ Kicman, A T (2008). "Pharmacology of anabolic steroids". British Journal of Pharmacology. 154 (3): 502–521. doi:10.1038/bjp.2008.165. ISSN 0007-1188.
- 1 2 Eberhard Nieschlag; Hermann M. Behre; Susan Nieschlag (13 January 2010). Andrology: Male Reproductive Health and Dysfunction. Springer Science & Business Media. pp. 442–. ISBN 978-3-540-78355-8.